A novel recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing human granulocyte macrophage colony-stimulating factor and Mycobacterium tuberculosis early secretory antigenic target 6 complex augments Th1 immunity

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 7, 2011, Pages 511-518

  Yang, Xiaoling ^a   Bao, Lang ^a   Deng, Yihao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

ESAT6; GM CSF; Th1 immunity

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BCG VACCINE; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN;

ADULT; ANIMAL; ARTICLE; BIOSYNTHESIS; HUMAN; IMMUNOLOGY; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; TH1 CELL;

ADULT; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MICE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; TH1 CELLS; TUBERCULOSIS VACCINES;

MUS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 79960131428     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmr045     Document Type: Article

References (38)

1. Blanc L, Falzon D, Fitzpatrick C, Floyd K, Garcia I, Glaziou P and Gunneberg C, et al. Global tuberculosis control: key findings from the December 2009 WHO report. Releve epidemiologique hebdomadaire/Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record/Health Section of the Secretariat of the League of Nations 2010, 85: 69-80.
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC and Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163: 1009-1021. (Pubitemid 36548927)
3. Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A and Hoffner S, et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001, 344: 1294-1303. (Pubitemid 32377203)
4. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV and Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994, 271: 698-702. (Pubitemid 24061706)
5. Brewer TF. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 2000, 31: S64-S67. (Pubitemid 32269590)
6. Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, Braskamp G and van der Werff NM, et al. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PloS One 2009, 4: e5264.
7. Zhang H, Peng P, Miao S, Zhao Y, Mao F, Wang L and Bai Y, et al. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice. Scand J Immunol 2010, 72: 349-357.
8. Olsen AW, Williams A, Okkels LM, Hatch G and Andersen P. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 2004, 72: 6148-6150. (Pubitemid 39303732)
9. Bai Y, Xue Y, Gao H, Wang L, Ding T, Bai W and Fan A, et al. Expression and purification of Mycobacterium tuberculosis ESAT-6 and MPT64 fusion protein and its immunoprophylactic potential in mouse model. Protein Expr Purif 2008, 59: 189-196.
10. Luo Y, Wang B, Hu L, Yu H, Da Z, Jiang W and Song N. Fusion protein Ag85B-MPT64190-198-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. Vaccine 2009, 27: 6179-6185.
11. Fan X, Gao Q and Fu R. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model. Microbiol Res 2009, 164: 374-382.
12. Derrick SC, Yang AL and Morris SL. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 2004, 23: 780-788. (Pubitemid 39473176)
13. Sugawara I, Sun L, Mizuno S and Taniyama T. Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis. Tuberculosis (Edinb) 2009, 89: 62-67.
14. Xu Y, Zhu B, Wang Q, Chen J, Qie Y, Wang J and Wang H, et al. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice. FEMS Immunol Med Microbiol 2007, 51: 480-487. (Pubitemid 350076157)
15. Wang QL PQ, Ma Y, Wang K, Sun P, Liu S and Zhang XL. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine 2009, 27: 6712-6722.
16. Wang J, Thorson L, Stokes RW, Santosuosso M, Huygen K, Zganiacz A and Hitt M, et al. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 2004, 173: 6357-6365. (Pubitemid 39487795)
17. Grode L, Seiler P, Baumann S, Hess J, Brinkmann V and Nasser Eddine A, et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 2005, 115: 2472-2479. (Pubitemid 41266209)
18. Horwitz MA, Harth G, Dillon BJ and Maslesa-Galic S. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30 kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000, 97: 13853-13858.
19. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D and Gordon SV, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998, 393: 537-544. (Pubitemid 28319235)
20. Pym AS, Brodin P, Brosch R, Huerre M and Cole ST. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 2002, 46: 709-717. (Pubitemid 35365606)
21. Bao L, Chen W, Zhang H and Wang X. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guerin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis. Infect Immun 2003, 71: 1656-1661. (Pubitemid 36368694)
22. Wang LM, Shi CH, Fan XL, Xue Y, Bai YL and Xu ZK. Expression and immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guerin strain secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice. Chin Med J (Engl) 2007, 120: 1220-1225. (Pubitemid 47232904)
23. Fan XL, Yu TH, Gao Q and Yao W. Immunological properties of recombinant Mycobacterium bovis bacillus Calmette-Guerin strain expressing fusion protein IL-2-ESAT-6. Acta Biochim Biophys Sin 2006, 38: 683-690. (Pubitemid 44657212)
24. Xu Y, Liu W, Shen H, Yan J, Qu D and Wang H. Recombinant Mycobacterium bovis BCG expressing the chimeric protein of antigen 85B and ESAT-6 enhances the Th1 cell-mediated response. Clin Vaccine Immunol 2009, 16: 1121-1126.
25. Deng YH, Sun Z, Yang XL and Bao L. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guerin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis. Scand J Immunol 2010, 72: 332-338.
26. Burger JA, Baird SM, Powell HC, Sharma S, Eling DJ and Kipps TJ. Local and systemic effects after adenoviral transfer of the murine granulocyte-macrophage colony-stimulating factor gene into mice. Br J Haematol 2000, 108: 641-652. (Pubitemid 30196263)
27. Yuan S, Shi C, Han W, Ling R, Li N and Wang T. Effective anti-tumor responses induced by recombinant bacillus Calmette-Guerin vaccines based on different tandem repeats of MUC1 and GM-CSF. Eur J Cancer Prev 2009, 18: 416-423.
28. Miller G, Pillarisetty VG, Shah AB, Lahrs S, Xing Z and DeMatteo RP. Endogenous granulocyte-macrophage colony-stimulating factor overexpression in vivo results in the long-term recruitment of a distinct dendritic cell population with enhanced immunostimulatory function. J Immunol 2002, 169: 2875-2885. (Pubitemid 35013128)
29. Gonzalez-Juarrero M, Hattle JM, Izzo A, Junqueira-Kipnis AP, Shim TS, Trapnell BC and Cooper AM, et al. Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection. J Leukoc Biol 2005, 77: 914-922. (Pubitemid 40770843)
30. Stover CK, de la Cruz VF, Fuerst TR, Burlein JE, Benson LA, Bennett LT and Bansal GP, et al. New use of BCG for recombinant vaccines. Nature 1991, 351: 456-460. (Pubitemid 21896614)
31. Shi C, Chen L, Chen Z, Zhang Y, Zhou Z, Lu J and Fu R, et al. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein. Vaccine 2010, 28: 5237-5244.
32. Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, Behr MA and Sherman DR. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille calmette-guerin attenuation. J Infect Dis 2003, 187: 117-123. (Pubitemid 36034479)
33. Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A and Griffiths KE, et al. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 2003, 9: 533-539. (Pubitemid 36597098)
34. Ravn P, Demissie A, Eguale T, Wondwosson H, Lein D, Amoudy HA and Mustafa AS, et al. Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 1999, 179: 637-645. (Pubitemid 30016147)
35. Ryan AA, Wozniak TM, Shklovskaya E, O'Donnell MA, Fazekas de St Groth B, Britton WJ and Triccas JA. Improved protection against disseminated tuberculosis by Mycobacterium bovis bacillus Calmette-Guerin secreting murine GM-CSF is associated with expansion and activation of APCs. J Immunol 2007, 179: 8418-8424.
36. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR and Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 1999, 162: 5407-5416. (Pubitemid 29307149)
37. + T cells correlate with active Mycobacterium tuberculosis infection. Eur J Immunol 2010, 40: 2211-2220.
38. + T cells in tuberculosis. Am J Respir Crit Care Med 2002, 166: 1116-1121. (Pubitemid 35178711)